Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
December 2025: Emcure Pharmaceuticals launched Poviztra, a semaglutide-based weight-loss therapy, at USD 106 (INR 8,790) per month, becoming the first Indian company to commercialize Novo Nordisks molecule for obesity
.png)
Frequent or severe vomiting is not normal and should be reported immediately
However, some of these findings come from animal experiments, observational studies, or early-stage clinical trials
The SMG group (once 2.4 mg, once a week) was treated for 68 weeks, and the average weight loss in the SMG group was 15.3 kg
US$ 27.15
US$ 25.55
US$ 21.12
US$ 23.54
